Artemether specification 1.Artemisinin NLT 99% HPLC 2.GMP Factory 3.Type: Herbal Extract 4.Cas. No.: 63968-64-9 Product Name Artemether Analysis: 225kgs Active Ingredient Artemether Quantity 225kgs Analysis Items Specifications (USP32) Resules Test Methods Identification Positive Conforms TLC…
1.Artemisinin NLT 99% HPLC
3.Type: Herbal Extract
4.Cas. No.: 63968-64-9
|Analysis Items||Specifications (USP32)||Resules||Test Methods|
|Appearance||White color cream crystalline powder||Conforms||Visual|
|Melting Point||168°C– 173°C||169°C||Visual|
|Assay (by drying sample)||98.0 –102.0 %||99.18%||HPLC|
|Loss on Drying(At 80°C)||NMT 0.5%||0.32%||/|
|Residue On ignition||NMT 0.1%||0.06%||/|
|Moisture Content(5g)||NMT 5.0%||2.51%||5g/105C/2hrs|
|Ash Content (2g)||NMT 5.0%||2.36%||2g/525C/3hrs|
|Heavy Metals||NMT 10ppm||Conforms||Atomic Absorption|
|Packing and Storage||Pack in paper-drums and two plastic-bags inside .|
|Shelf Life||2 years if sealed and store away from direct sun light|
Artemisia annua is used by Chinese medicine to treat fever (especially not malaria) and many other ills, including malaria.
Artemisinin extracts have been used for centuries to kill parasites, especially worms and trematodes.
Artemisinin has proven to be a safe and effective treatment for malaria, with more than 2 million patients taking malaria.
As shown in a series of successful experiments, artemisinin is effective against various cancers. The most effective are leukemia and colon cancer. Intermediate activities against melanoma, breast cancer, ovarian cancer, prostate cancer, CNS and renal cancer are also shown.
Artemisinin can also increase lymphocyte transformation rate and promote cellular immunity; artemisinin can slow heart rate, inhibit myocardial contractility, and reduce
Before bulk order,Sample is available. Customer only pay the delivery cost.
You can send us email for your required product details.
We will send you the Updated Documents by Email
Hot Tags: artemether lumefantrine powder, suppliers, customized, bulk, made in China